HOME >> BIOLOGY >> NEWS
Creation of gene targeting earns Smithies March of Dimes honor

CHAPEL HILL--For developing an indispensable tool for genetic disease research, two scientists have been named co-recipients of this year's March of Dimes Prize in Developmental Biology, to be awarded Monday (May 16) in Washington, D.C.

Drs. Oliver Smithies, Excellence Professor of pathology and laboratory medicine at the University of North Carolina at Chapel Hill School of Medicine, and Mario R. Capecchi, Distinguished Professor of human genetics at the University of Utah, are being honored for developing gene targeting.

Their technique gives scientists around the world the ability to alter particular genes in cultured cells and transfer those targeted genes to laboratory mice. Gene targeting thus allows them to design and produce "knockout" lab mice to study how the disabled gene works.

The same technology also makes it possible to change the function of a gene "knock in" -- or restore the function of a disabled gene. Because humans share the vast majority of their genes with mice, gene-targeted mice are used to reproduce diseases that occur in humans.

The March of Dimes Prize is a cash award of $250,000 and a silver medal in the design of the Roosevelt dime, in honor of President Franklin Delano Roosevelt, who founded the March of Dimes.

"Before gene targeting, researchers could not pinpoint how a specific gene worked, which was very frustrating," said Dr. Jennifer L. Howse, president of the March of Dimes. "Dr. Capecchi and Dr. Smithies, working independently, made a technological breakthrough that completely revolutionized biomedical research and our ability to study human disease and development. We're reaping the benefits every day with advances in genetic medicine."

Gene targeting is now practiced routinely by thousands of scientists all over the world, enabling them to address the most complex and critical biological problems, including the causes and treatment of birth defects and many other disorders, such
'"/>

Contact: David Williamson
919-962-8596
University of North Carolina at Chapel Hill
11-May-2005


Page: 1 2

Related biology news :

1. Creation of an international industrial chair in life cycle assessment
2. Creation of an international research network
3. Creation of antibiotic in test tube holds promise for better antibiotics
4. Creationism is not science making the case for Darwin at UCL
5. Bulls-eye -- Programs targeting math, science teacher shortage may get boost
6. AACR Annual Meeting showcases significant developments in understanding and targeting cancers
7. Researchers find stem-cell therapy effective in targeting metastatic cancer
8. By analyzing and targeting specific germs, hospital hopes to improve pneumonia treatment
9. Pain killer fights breast cancer by targeting key enzyme
10. Oncologists could gain therapeutic advantage by targeting telomere protein
11. Understanding IGF-1: Jefferson researcher sees drug potential in targeting enzyme

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition Market ... Application Area, End User, And Region - Global Forecast to 2021", published by ... 2016 to USD 36.07 Billion by 2021, at a Compound Annual Growth Rate ... ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... an offering of €500.0 million principal amount of its 1.414% ... of its 2.425% senior unsecured notes due 2026. ... on December 13, 2016, subject to the satisfaction of customary closing ... The Company intends to use ...
(Date:12/2/2016)... India , December 1, 2016 ... Authentication type (Fingerprint, Voice), Future Technology (Iris Recognition ... and Region - Global Forecast to 2021", published ... USD 442.7 Million in 2016, and is projected ... at a CAGR of 14.06%.      ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  OncoSec Medical Incorporated ("OncoSec") ... DNA-based intratumoral cancer immunotherapies, today announced financial results ... "We are delivering on our commitment to ... ImmunoPulse® IL-12. We are pleased with the early ... trial, and we are focused on advancing our ...
(Date:12/8/2016)...  Biotheranostics today announced that new data will ... Cancer Index (BCI) in identifying which patients with ... for disease recurrence and might benefit from extended ... advancing the understanding of the value of BCI ... inform decisions related to patient treatment. These data ...
(Date:12/8/2016)... UK (PRWEB) , ... December 08, 2016 , ... ... precision light to control cells — optogenetics — is key to exciting advances ... of the art, spatially patterned light projected via free-space optics stimulates small, transparent ...
(Date:12/8/2016)... -- Oxford Gene Technology (OGT), The ... range with the launch of the SureSeq myPanel™ NGS Custom ... in familial hypercholesterolemia (FH). The panel delivers single nucleotide variation ... small panel and allows customisation by ,mix and match, of ... LDLR , P C SK9 , ...
Breaking Biology Technology:
Cached News: